Association Between ERCC1 rs3212986 and ERCC2/XPD rs1799793 and OS in Patients With Advanced Esophageal CancerFRONTIERS IN ONCOLOGYIF3.32019-02-217OAAI
Detection of genetic alterations in cfDNA as a possible strategy to monitor the neoplastic progression of Barrett's esophagusTRANSLATIONAL RESEARCHIF5.92017-12-0120PREAI
Liquid biopsy as a novel tool to monitor the carcinogenesis of Barrett's esophagusTRANSLATIONAL RESEARCHIF5.92016-10-019PREAI
Circulating cell free DNA (cfDNA) as a novel tool to monitor Barrett's esophagus neoplastic progressionEUROPEAN JOURNAL OF CANCERIF7.12016-07-010PREAI
A germline predictive signature of response to platinum chemotherapy in esophageal cancerTRANSLATIONAL RESEARCHIF5.92016-05-0117PREAI
Genetic variants of susceptibility in second primary esophageal cancer patientsEUROPEAN JOURNAL OF CANCERIF7.12014-07-010PREAI
An array-based pharmacogenetic study on elderly patients with advanced breast cancer treated with aromatase inhibitorsEUROPEAN JOURNAL OF CANCERIF7.12014-07-010PREAI
Copy Number Profile of Esophageal Cancer - Comparative Analysis of Adenocarcinoma and Squamous Cell CarcinomaEUROPEAN JOURNAL OF CANCERIF7.12012-07-010PREAI
Genetic Polymorphisms as Predictive/prognostic Biomarkers in Esophageal Cancer Patients Receiving Cisplatin/5-Fluorouracil-based Neoadjuvant ChemotherapyEUROPEAN JOURNAL OF CANCERIF7.12012-07-010PREAI
Ras signaling contributes to survival of human T-cell leukemia/lymphoma virus type 1 (HTLV-1) Tax-positive T-cellsAPOPTOSISIF8.12011-11-3019OAAI
DNA copy number profile discriminates between esophageal adenocarcinoma and squamous cell carcinoma and represents an independent prognostic parameter in esophageal adenocarcinomaCANCER LETTERSIF10.12011-11-0113PRE
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向